Literature DB >> 32911560

COVID-19 and Sodium-Glucose Cotransporter 2 Inhibitors: No Fear to Attempt?

Stella Papachristou1, Theano Penlioglou1, Anca Pantea Stoian2, Nikolaos Papanas1.   

Abstract

Novel coronavirus infectious disease (COVID-19) has been recognised as a pandemic by the World Health Organization (WHO) 1. Mortality and morbidity are higher in elderly individuals and those with comorbidities, such as diabetes mellitus (DM), obesity, hypertension, respiratory tract diseases, coronary heart disease or cancer 1. Indeed, two thirds of individuals who died from COVID-19 had DM in Italy 2. Thieme. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32911560     DOI： 10.1055/a-1235-5617

Source DB:  PubMed          Journal:  Exp Clin Endocrinol Diabetes        ISSN： 0947-7349            Impact factor:   2.949


  3 in total

1.  Acute surgical abdomen during the COVID-19 pandemic: Clinical and therapeutic challenges.

Authors:  Dragos Serban; Bogdan Socea; Cristinel Dumitru Badiu; Corneliu Tudor; Simona Andreea Balasescu; Dan Dumitrescu; Andra Maria Trotea; Radu Iulian Spataru; Geta Vancea; Ana Maria Dascalu; Ciprian Tanasescu
Journal:  Exp Ther Med       Date:  2021-03-22       Impact factor: 2.447

Review 2.  COVID-19 and the kidney: time to take a closer look.

Authors:  Vassilios Liakopoulos; Stefanos Roumeliotis; Stella Papachristou; Nikolaos Papanas
Journal:  Int Urol Nephrol       Date:  2021-08-12       Impact factor: 2.266

Review 3.  Management of patients with diabetes and obesity in the COVID-19 era: Experiences and learnings from South and East Europe, the Middle East, and Africa.

Authors:  Francesco Giorgino; Sindeep Bhana; Leszek Czupryniak; Selcuk Dagdelen; Gagik R Galstyan; Andrej Janež; Nebojsa Lalić; Nassim Nouri; Dario Rahelić; Anca Pantea Stoian; Itamar Raz
Journal:  Diabetes Res Clin Pract       Date:  2020-12-10       Impact factor: 8.180
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.